Rights and Permissions
Sirui Ma, Soumon Rudra, Jian L Campian, Sonika Dahiya, Gavin P Dunn, Tanner Johanns, Michael Goldstein, Albert H Kim, Jiayi Huang, Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma, Neuro-Oncology Advances, Volume 2, Issue 1, January-December 2020, vdaa126, https://doi.org/10.1093/noajnl/vdaa126.
© The Author(s) 2020. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Ma, Sirui; Rudra, Soumon; Campian, Jian L; Dahiya, Sonika; Dunn, Gavin P; Johanns, Tanner; Goldstein, Michael; Kim, Albert H; and Huang, Jiayi, "Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma." Neuro-Oncology Advances. 2, 1. vdaa126 (2020).